Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve precision medicine and find cures for all known diseases.
Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

Tags:artificial intelligencebiotechcovid19cure diseasesdigitaldigital technologydisruptionDrug blueprintsdrug designdrug discoveryfireside chathealthcarehealthcare innovationhealthtechimpetusimpetus digitalInnovationlife sciencesmachine learningmarket researchmedicalpatientspersonalized medicinePOLARISqbprecision medicinequantum biotechquantum computingquantum molecular designShahar KeinanTechnologyvirtual advisory boards